Antibodies
11 July 2007
Peregrine Pharmaceuticals Initiates Bavituximab Clinical Trial in HCV Patients Co-Infected With HIV3 July 2007
Ablynx announces interim results of first nanobody (R) phase i study of ALX-0081 (anti-vWF)30 June 2007
Genmab regains rights to HuMax-CD430 June 2007
WILEX to follow FDA advice and apply for a special protocol assessment (SPA) for CA9-SCAN23 June 2007
Alexion’s Soliris(TM) granted marketing approval in europe for treatment of all patients with PNH19 June 2007
Vegenics Licenses From CoGenesys Antibodies Against VEGF-C for Applications Including Oncology16 June 2007
Actemra: Roche’s novel rheumatoid arthritis drug shows substantial benefits for patients in OPTION study15 June 2007
Genmab initiates ofatumumab frontline NHL study12 June 2007
Viventia Biotech initiates patient treatment for Phase I trial of VB6-845 anti-cancer antibody8 June 2007
Remicade(R) Receives EU Approval as First and Only Biologic Treatment for Pediatric Crohn’s DiseaseNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports